Validation of Circulating Tumor DNA Assays for Detection of Metastatic Melanoma
Mahrukh M. Syeda(NYU Langone Health), David Polsky(New York University), Jennifer Wiggins(New York University), Broderick C. Corless(Cornell University), George Karlin‐Neumann(Bio-Rad (United States)), Cindy Spittle(SunEdison (United States))
Cited by 12
Related Papers
High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy Number
|Analytical Chemistry|2011|2.8k
Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Metastatic Melanoma
|Clinical Cancer Research|2008|188
Circulating tumour DNA in patients with advanced melanoma treated with dabrafenib or dabrafenib plus trametinib: a clinical validation study
|The Lancet Oncology|2021|96
The Diagnostic Performance of Expert Dermoscopists vs a Computer-Vision System on Small-Diameter Melanomas
|Archives of Dermatology|2008|88
<em>MC1R</em> variants as melanoma risk factors independent of at-risk phenotypic characteristics: a pooled analysis from the M-SKIP project
|Cancer Management and Research|2018|74